Square Pharmaceuticals PLC. (DSE: SQURPHARMA)
Bangladesh
· Delayed Price · Currency is BDT 224.90
+0.50 (0.22%)
At close: Nov 14, 2024
SQURPHARMA Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Net Income | 18,980 | 18,980 | 18,157 | 15,947 | 13,354 | 12,646 | Upgrade
|
| Depreciation & Amortization | 2,310 | 2,310 | 1,835 | 1,882 | 1,921 | 2,014 | Upgrade
|
| Other Amortization | - | - | - | - | 49.49 | 13.5 | Upgrade
|
| Loss (Gain) From Sale of Assets | 79.8 | 79.8 | -53.49 | -34.43 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | -177.04 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | -2,523 | -2,523 | -2,011 | -1,291 | - | - | Upgrade
|
| Other Operating Activities | 993.31 | -4,654 | -3,838 | -3,330 | -3,698 | -3,085 | Upgrade
|
| Change in Accounts Receivable | -1,363 | -1,363 | -522.93 | -115.84 | 41.52 | 54.58 | Upgrade
|
| Change in Inventory | -4,177 | -4,177 | -968.71 | -1,558 | -1,091 | -39.43 | Upgrade
|
| Change in Accounts Payable | 375.77 | 375.77 | -40.18 | 127.76 | -163.2 | 168.03 | Upgrade
|
| Change in Income Taxes | -555.41 | -555.41 | 338.83 | -405.36 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 71.59 | 71.59 | -22.88 | -69.56 | 347.24 | 619.67 | Upgrade
|
| Operating Cash Flow | 14,192 | 8,546 | 12,875 | 10,976 | 10,760 | 12,392 | Upgrade
|
| Operating Cash Flow Growth | 37.94% | -33.62% | 17.29% | 2.01% | -13.17% | 25.10% | Upgrade
|
| Capital Expenditures | -3,853 | -2,824 | -6,183 | -3,798 | -2,042 | -2,049 | Upgrade
|
| Sale of Property, Plant & Equipment | 78.33 | 78.33 | 130.7 | 80.13 | 60.74 | 66.59 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -209.05 | Upgrade
|
| Investment in Securities | -1,274 | -597.32 | -1,416 | -798.2 | -2,413 | 116.43 | Upgrade
|
| Other Investing Activities | -1,639 | 4,167 | 3,499 | 3,239 | 2,939 | 1,867 | Upgrade
|
| Investing Cash Flow | -6,688 | 823.95 | -3,970 | 3,607 | -1,866 | 169.31 | Upgrade
|
| Long-Term Debt Issued | - | 72.7 | 1,811 | 103.71 | - | - | Upgrade
|
| Total Debt Issued | 54.5 | 72.7 | 1,811 | 103.71 | - | - | Upgrade
|
| Total Debt Repaid | -438.96 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -384.45 | 72.7 | 1,811 | 103.71 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.5 | - | - | Upgrade
|
| Common Dividends Paid | -9,235 | -8,803 | -5,302 | -3,923 | -3,314 | -2,655 | Upgrade
|
| Other Financing Activities | -32.23 | -32.23 | -262.5 | - | - | - | Upgrade
|
| Financing Cash Flow | -9,652 | -8,762 | -3,754 | -3,819 | -3,314 | -2,655 | Upgrade
|
| Foreign Exchange Rate Adjustments | 57.3 | 524.71 | 447.1 | 35.61 | -20.05 | 32.44 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | 84.69 | Upgrade
|
| Net Cash Flow | -2,090 | 1,132 | 5,598 | 10,800 | 5,560 | 10,024 | Upgrade
|
| Free Cash Flow | 10,339 | 5,721 | 6,692 | 7,178 | 8,718 | 10,343 | Upgrade
|
| Free Cash Flow Growth | 48.37% | -14.50% | -6.78% | -17.66% | -15.71% | 53.50% | Upgrade
|
| Free Cash Flow Margin | 15.03% | 9.12% | 11.62% | 14.16% | 19.00% | 23.49% | Upgrade
|
| Free Cash Flow Per Share | 11.66 | 6.45 | 7.55 | 8.10 | 9.83 | 11.67 | Upgrade
|
| Cash Interest Paid | 215.82 | 87.68 | 0.03 | 0.01 | 0.11 | 0.1 | Upgrade
|
| Cash Income Tax Paid | 4,697 | 5,127 | 4,494 | 4,595 | 3,831 | 3,565 | Upgrade
|
| Levered Free Cash Flow | 5,500 | 2,984 | 4,800 | 10,672 | 5,455 | 9,147 | Upgrade
|
| Unlevered Free Cash Flow | 5,634 | 3,058 | 4,800 | 10,672 | 5,455 | 9,148 | Upgrade
|
| Change in Net Working Capital | 3,861 | 6,859 | 1,390 | -3,045 | 3,142 | -824.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.